My NCBISign In
Interleukin-6 and rheumatic diseases
Peter E Lipsky
Arthritis Res Ther. 2006; 8(Suppl 2): S4. Published online 2006 July 28. doi: 10.1186/ar1918
PMCID:
PMC2946778
Abstract Full Text PDF–414K

Is Cited by the Following 5 Articles in this Archive:

TNF-α promotes LPA1- and LPA3-mediated recruitment of leukocytes in vivo through CXCR2 ligand chemokines
Chenqi Zhao, Anne Sardella, Jerold Chun, Patrice E. Poubelle, Maria J. Fernandes, Sylvain G. Bourgoin
J Lipid Res. 2011 July; 52(7): 1307–1318. doi: 10.1194/jlr.M008045
PMCID:
PMC3111742
Free in PMC on 2012/07/01
Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis
Bailin Liang, Zheng Song, Bin Wu, Debra Gardner, David Shealy, Xiao-Yu Song, Paul H Wooley
J Inflamm (Lond) 2009; 6: 10. Published online 2009 April 15. doi: 10.1186/1476-9255-6-10
PMCID:
PMC2673212
Abstract Full Text PDF–1.3M
Current status and challenges of cytokine pharmacology
Z Zídek, P Anzenbacher, E Kmoníčková
Br J Pharmacol. 2009 June; 157(3): 342–361. Published online 2009 April 3. doi: 10.1111/j.1476-5381.2009.00206.x
PMCID:
PMC2707982
Abstract Full Text PDF–2.8M
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
Stephanie Hennigan, Arthur Kavanaugh
Ther Clin Risk Manag. 2008 August; 4(4): 767–775. Published online 2008 August.
PMCID:
PMC2621374
Abstract Full Text PDF–91K
Developments in lupus 2006
Arne Hansen, Falk Hiepe, Thomas Dörner
Arthritis Res Ther. 2007; 9(4): 215. Published online 2007 July 11. doi: 10.1186/ar2183
PMCID:
PMC2206361
Abstract Full Text PDF–89K
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk